Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.
暂无分享,去创建一个
A. Gottlieb | L. Diller | E. Sexsmith | A. Gottlieb | F. Li | D. Malkin | Frederick P. Li | D. Malkin | F. Li | F. Li
[1] J. Fraumeni,et al. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. , 1969, Journal of the National Cancer Institute.
[2] J. Fraumeni,et al. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.
[3] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Knudson,et al. Mutation and cancer: a model for Wilms' tumor of the kidney. , 1972, Journal of the National Cancer Institute.
[5] B Langholz,et al. Childhood cancer incidence: Geographical and temporal variations , 1983, International journal of cancer.
[6] M. Isobe,et al. Localization of gene for human p53 tumour antigen to band 17p13 , 1986, Nature.
[7] L. Crawford,et al. Characterization of the human p53 gene , 1986, Molecular and cellular biology.
[8] D. Givol,et al. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[9] G. Draper,et al. Incidence of second primary tumours among childhood cancer survivors. , 1987, British Journal of Cancer.
[10] W. Blattner,et al. A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.
[11] F. Collins,et al. Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.
[12] A. Levine,et al. The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.
[13] S. Donaldson,et al. An attempt to use a common staging system in rhabdomyosarcoma: a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). , 1989, Medical and pediatric oncology.
[14] W. Blattner,et al. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.
[15] L. Strong,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.
[16] W. Cavenee,et al. Mechanisms of p53 loss in human sarcomas. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Birch,et al. Malignant disease in the mothers of a population-based series of young adults with bone and soft tissue sarcomas. , 1991, British Journal of Cancer.
[18] R. Katakura,et al. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1991, Oncogene.
[19] J. Fraumeni,et al. Follow-up study of twenty-four families with Li-Fraumeni syndrome. , 1991, Cancer research.
[20] A. Craft,et al. p53 germline mutations in Li-Fraumeni syndrome , 1991, The Lancet.
[21] L. Strong,et al. A germ line mutation in exon 5 of the p53 gene in an extended cancer family. , 1991, Cancer research.
[22] B. Emanuel,et al. Localization of the rhabdomyosarcoma t(2;13) breakpoint on a physical map of chromosome 13. , 1991, Genomics.
[23] V. Sheffield,et al. Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. Carbone,et al. Polymorphism at codon 213 within the p53 gene. , 1991, Oncogene.
[25] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[26] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[27] D. Lane,et al. Abnormal expression of wild type p53 protein in normal cells of a cancer family patient , 1992, The Lancet.
[28] J. Whang‐Peng,et al. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. , 1992, The Journal of clinical investigation.
[29] S. Friend,et al. Screening for germ line TP53 mutations in breast cancer patients. , 1992, Cancer research.
[30] P. Meltzer,et al. Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.
[31] B. Vogelstein,et al. Inherited p53 gene mutations in breast cancer. , 1992, Cancer research.
[32] S. Friend,et al. Cancer risks from germline p53 mutations. , 1992, The Journal of clinical investigation.
[33] Cell cycle regulation and the p53 tumor suppressor protein. , 1992 .
[34] R. Weichselbaum,et al. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. , 1992, The New England journal of medicine.
[35] S. Friend,et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. , 1992, The New England journal of medicine.
[36] A. Iavarone,et al. Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[37] E. Appella,et al. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[39] J. Yokota,et al. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. , 1992, Journal of the National Cancer Institute.
[40] C. Felix,et al. Frequency and Diversity of P53 Mutations in Childhood Updated Version Citing Articles E-mail Alerts Frequency and Diversity of P53 Mutations in Childhood Rhabdomyosarcoma , 1992 .
[41] Thierry Soussi,et al. TP53 tumor suppressor gene: A model for investigating human mutagenesis , 1992, Genes, chromosomes & cancer.
[42] C. Purdie,et al. Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.
[43] C. Bonaïti‐pellié,et al. Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. , 1993, Cancer research.
[44] B. Gallie,et al. Mutations of the p53 gene do not occur in testis cancer. , 1993, Cancer research.
[45] P. Meltzer,et al. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. , 1993, Cancer research.
[46] M. Oren,et al. Sequence‐specific DNA binding by p53: identification of target sites and lack of binding to p53 ‐ MDM2 complexes. , 1993, The EMBO journal.
[47] M. Hollstein,et al. Clinical implications of the p53 tumor-suppressor gene. , 1993, The New England journal of medicine.
[48] Scott W. Lowe,et al. p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.
[49] A. Craft,et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. , 1994, Cancer research.
[50] S. Friend,et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] C. Portwine,et al. High frequency of germline p53 mutations in childhood adrenocortical cancer. , 1994, Journal of the National Cancer Institute.